SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-11.36%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$1.05B
(-22%)
Cap. Flow
-$67.4M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
68.08%
Holding
76
New
16
Increased
8
Reduced
12
Closed
14
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.6M |
| 2 |
Merck
MRK
|
$17.2M |
| 3 |
Align Technology
ALGN
|
$8.09M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
$5.86M |
| 5 |
Puma Biotechnology
PBYI
|
$5.39M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$18.8M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$17.1M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$14M |
| 4 |
Fate Therapeutics
FATE
|
$13.3M |
| 5 |
MacroGenics
MGNX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 98.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $136M | 12.56% | 1,885,602 | – | – |
|
2
Ascendis Pharma
ASND
$11.8B
| $125M | 11.56% | 1,109,874 | – | – |
|
3
NextCure
NXTC
$13.5M
| $99M | 9.16% | 2,671,856 | – | – |
|
4
Natera
NTRA
$23.1B
| $92.6M | 8.56% | 3,100,560 | – | – |
|
|
PRNB
5
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $84.2M | 7.78% | 1,417,258 | – | – |
|
6
Y-mAbs Therapeutics
YMAB
$388M
| $57.3M | 5.3% | 2,194,278 | – | – |
|
|
7
Merck
MRK
$210B
| $35.7M | 3.3% | 463,795 +222,989 | +93% | +$17.2M |
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $31.4M | 2.9% | 1,933,221 | – | – |
|
|
GRTX
9
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $29.3M | 2.71% | 3,083,712 | – | – |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $27.6M | 2.55% | +307,300 | New | +$27.6M |
|
11
Merus
MRUS
$4.98B
| $23.7M | 2.19% | 1,961,039 | – | – |
|
12
United Therapeutics
UTHR
$13.8B
| $22.1M | 2.05% | 233,559 +44,914 | +24% | +$4.26M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $20.8M | 1.93% | 5,208,305 | – | – |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $20.4M | 1.89% | 85,664 -53,500 | -38% | -$12.7M |
|
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $20.3M | 1.88% | 240,046 -201,826 | -46% | -$17.1M |
|
16
Biogen
BIIB
$19.4B
| $16.7M | 1.54% | 52,628 -11,083 | -17% | -$3.51M |
|
|
XLRN
17
DELISTED
Acceleron Pharma Inc.
XLRN
| $14.8M | 1.37% | 165,160 +18,128 | +12% | +$1.63M |
|
18
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $14.3M | 1.32% | 922,700 | – | – |
|
|
NCNA
19
NuCana
NCNA
$6.09M
| $13.2M | 1.22% | 2,266,666 | – | – |
|
20
PTC Therapeutics
PTCT
$3.92B
| $13M | 1.21% | 292,217 -224,875 | -43% | -$10M |
|
|
OBSV
21
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $11.4M | 1.06% | 4,749,623 | – | – |
|
22
Sarepta Therapeutics
SRPT
$1.78B
| $9.94M | 0.92% | 101,603 +13,785 | +16% | +$1.35M |
|
23
KALA BIO
KALA
$78.8M
| $9.8M | 0.91% | 1,114,520 +449,879 | +68% | +$3.95M |
|
|
MYOK
24
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.21M | 0.76% | 175,118 -20,753 | -11% | -$973K |
|
|
25
Align Technology
ALGN
$10.3B
| $8.09M | 0.75% | +46,500 | New | +$8.09M |
|